Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
529,598
-
Shares change
-
+34,170
-
Total reported value, excl. options
-
$98,372,552
-
Value change
-
+$6,457,088
-
Number of buys
-
41
-
Number of sells
-
-37
-
Price
-
$185.74
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2021
111 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q2 2021.
ISHARES TR - U.S. PHARMA ETF (IHE) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 529,598 shares
.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (60,374 shares), ROYAL BANK OF CANADA (50,512 shares), MORGAN STANLEY (45,596 shares), CITADEL ADVISORS LLC (40,239 shares), BROWN ADVISORY INC (37,606 shares), BANK OF AMERICA CORP /DE/ (31,345 shares), RAYMOND JAMES & ASSOCIATES (29,180 shares), LPL Financial LLC (23,886 shares), UBS Group AG (22,445 shares), and MURPHY CAPITAL MANAGEMENT INC (18,930 shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.